EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS

EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS

Diğer sürümleri göster (1)

The article presents the results of a study of effectiveness and safety of infliximab — monoclonal antibodies to tumor necrotizing factor (TNF) _ in treatment of 47 patients in age 11 months — 16 years old with early pauciarticular and polyarticular types of juvenile rheumatoid arthritis. The durati...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: E.I. Alexeeva, T.V. Sleptsova, S.I. Valieva, T.M. Bzarova, R.V. Denisova, A.O. Lisitsin, E.Yu. Gudkova, A.M. Chomakhidze, K.B. Isaeva, A.A. Grigor’eva, O.L. Lomakina
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: "Paediatrician" Publishers LLC 2009-07-01
Seri Bilgileri:Вопросы современной педиатрии
Online Erişim:https://vsp.spr-journal.ru/jour/article/view/1142

Internet

https://vsp.spr-journal.ru/jour/article/view/1142

Benzer Materyaller